Biotechnology - Genomic and Proteomics/Open Business models in BGP: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Answer) |
||
| Line 1: | Line 1: | ||
[[Report April 2009]] | [[Report April 2009]] | ||
==Answer== | ==Answer== | ||
Open Source Biotechnology Project, ''Open source biotechnology?'', http://rsss.anu.edu.au/~janeth/OSBiotech.html | * TDI “A kernel for the Tropical Disease Initiative”, Leticia Ort’ et. al., Nature Publishing Group, | ||
** Problem it aims to address: open source drug development has not been successful because there lacks a critical mass of publicly available data. Focus on tropical diseases | |||
** Methodology: develop computational pipeline (e.g. open source data sets) for developing the following: | |||
structure modeling of target proteins | |||
** predictions of ligant bonding locations: (e.g., http://www.thesynapticleap.org/), public-private partnerships (e.g., http://www.mmv.org/) and private foundations (e.g., http://www.gatesfoundation.org/); | |||
** predict structures of protein sequences | |||
** products created from using the software do not seem to be required to be put in the public domain | |||
** Uses Science Commons protocol for implementing Open Access Data ((http://sciencecommons. | |||
org/projects/publishing/open-access-dataprotocol/) | |||
** Open Source Biotechnology Project, ''Open source biotechnology?'', http://rsss.anu.edu.au/~janeth/OSBiotech.html | |||
==Navigation== | ==Navigation== | ||
[[Bibliography for Item 12 in BGP]]<br> | [[Bibliography for Item 12 in BGP]]<br> | ||
[[Biotechnology_-_Genomic_and_Proteomics]] | [[Biotechnology_-_Genomic_and_Proteomics]] | ||
Revision as of 17:28, 21 April 2009
Answer
- TDI “A kernel for the Tropical Disease Initiative”, Leticia Ort’ et. al., Nature Publishing Group,
- Problem it aims to address: open source drug development has not been successful because there lacks a critical mass of publicly available data. Focus on tropical diseases
- Methodology: develop computational pipeline (e.g. open source data sets) for developing the following:
structure modeling of target proteins
- predictions of ligant bonding locations: (e.g., http://www.thesynapticleap.org/), public-private partnerships (e.g., http://www.mmv.org/) and private foundations (e.g., http://www.gatesfoundation.org/);
- predict structures of protein sequences
- products created from using the software do not seem to be required to be put in the public domain
- Uses Science Commons protocol for implementing Open Access Data ((http://sciencecommons.
org/projects/publishing/open-access-dataprotocol/)
- Open Source Biotechnology Project, Open source biotechnology?, http://rsss.anu.edu.au/~janeth/OSBiotech.html
Bibliography for Item 12 in BGP
Biotechnology_-_Genomic_and_Proteomics